Indications of piribedil in L-DOPA-treated parkinsonian patients: physiopathologic implications.
D000328:Adult; D000368:Aged; D001545:Benserazide / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009129:Muscle Tonus / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D010879:Piperazines / Q000627:therapeutic use*; D010891:Piribedil / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D012023:Reflex, Monosynaptic / Q000187:drug effects; D014202:Tremor / Q000188:drug therapy
D010879:Piperazines; D007980:Levodopa; D001545:Benserazide; D010891:Piribedil